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7 SUMMARY 
Analysis of differential gene expression of the tumour suppressor genes  
TGF-beta1-3 and its binding proteins LTBP-1, -3 and -4  
in canine mammary gland tumours 
 
52 % of the neoplastic diseases occurring by older dogs are tumours of the mammary gland.  
Various etiological and pathogenic factors are being discussed as a cause of the 
development of canine mammary gland tumours. Exogenous and endogenous factors are 
involved. A range of exogenous factors are for example chemical, physical, infectious and 
viral pathogens. Endogenous factors include especially age, gender, genetic and individual 
predispositions. 
Regarding the carcinogenetic mechanism on the molecular level it is considered that the 
pathogenesis involves cellular »nonlethal genetic damage« (mutation) of a cell which leads 
to neoplastic changes through clonal expansion of transformed cells. 
Concerning the genetic level three different classes of normal regulatory genes are principle 
targets of genetic damage. These include »growth promoting protooncogenes«, genes which 
lead to apoptosis, and the »growth inhibiting tumour suppressor genes«. 
The major growth inhibiting genes that are involved in the pathogenesis of canine mammary 
gland tumours are tumour suppressor genes such as TGF-ß-isoforms (Transforming growth 
factor-ß1-3) and their binding proteins the LTBP´s (Latent TGF-ß binding proteins 1, 3 and 
4). 
The aim of this dissertation included an evaluation of clinical data such as gender, age, 
breeding and neuter status of female dogs suffering from canine mammary gland tumours as 
well as a pathohistological classification of the excised tumours. Furthermore a quantitative 
genetic expression analysis of the gene expression profile of the tumour suppressor genes 
TGF-ß1, 2 and 3 as well as LTBP-1, -3 and -4 was done to evaluate the gene 
interdependencies in different classified canine mammary gland tumours. 
The accomplished data was derived from 45 canine mammary gland tumours of 31 female 
dogs. Approximately 44 % of the investigated bitches were half-breeds. A general statement 
concerning the occurrence of canine mammary gland tumours in relation to specific breeds 
can not be made due to lack of census data. The examined animals had an average age of 
9, 5 years and 90, 3 % of them were not neutered. The frequency of the occurring tumours 
increased from cranial to the caudal mammary gland complexes. 
The results of this study show the differential gene expression of the  
TGF-beta-isoforms 1–3 and the LTBP-isoforms 1, 3 and 4 considering the various stages of 
tumour progression as well as the different pathohistological classification of canine 
mammary gland tissue. 
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A definite tendency in the expression profile of the target genes in adenomas could not be 
determined regarding correlation and compensation mechanisms of all investigated genes. 
In simple carcinomas and complex carcinomas a similar expression pattern of the target 
genes (TGF-beta1, 2, 3 and LTBP-1, -3 and -4) could be statistically proved. The descriptive 
analysis showed a downregulation of TGF-beta1, whereas TGF-beta 2 and 3 were 
apparently not affected. LTBP-1 and LTPB-4 were downregulated and LTBP-3 showed an 
increased expression in these tumours.  
Finally the descriptive and analytical statistics showed various dependencies (correlation and 
compensation of expression) between following genes regarding simple carcinomas and 
complex carcinomas:  
»TGF-ß1 and TGF-ß2«, »TGF-ß1 and LTBP-1«, »TGF-ß1 and LTBP-3«, »TGF-ß1 and 
LTBP-4«, »TGF-ß2 and LTBP-3«,»TGF-ß2 and LTBP-4«, »TGF-ß3 and LTBP-4«, »LTBP-1 
and LTBP-4«  as well as »LTBP-3 and LTBP-4«.  
In highly malignant simple carcinomas an increased expression of TGF-beta1, LTBP-1  
and LTBP-3 was detected in the expression pattern of the target genes.  
The TGF-beta-isoforms 2 and 3 stayed unregulated and in addition LTBP-4 was 
downregulated in highly malignant simple carcinomas. 
The determined proportional expression of TGF-beta1 and LTBP-1 and 3 in different 
classified tumours indicates a correlation of expression of these target genes. This 
emphasizes the significance of latent TGF-beta binding proteins (LTBP-1 and 3) as 
modulators of the bioavailability of TGF-beta1. 
The discrepancy of the expression of TGF-beta1 in simple and complex carcinomas and 
highly malignant simple carcinomas confirms the dual role as well as the two-phasical 
behaviour of the cytokine in the genesis of epithelial neoplasia. 
In the early stage of tumour progression the cytokine TGF-beta1 performs as a 
tumoursuppressor. TGF-beta1 follows the signal transduction pathway and executes its 
function as a tumoursuppressor indirectly through inhibition of the progression of the cell 
cycle. In the late stage or in tumours of high malignancy TGF-beta1 promotes as a 
protooncogene in terms of local invasion and metastasis of tumours. 
Epithelial tumours may develop a resistance against the TGF-beta inducted growth inhibition 
which therefore documents an advanced progression in terms of malignant transformation. 
Furthermore TGF-beta1 induces an epithelial-to-mesenchymal transition (EMT). After the 
epithelial tumour converts to a mesenchymal phenotype TGF-beta1 promotes 
tumourprogression and –metastasis. 
